(2S,3R,4R,5R,6R)-2-(1-(5-Chloro-2-methoxyphenyl)-3-methyl-1H-1,2,4-triazol-5-yl)-6-(hydroxymethyl)4-(4-(3,4,5-trifiuorophenyl)-1H-1,2,3-triazol-1-yl)oxane-3,5-diol

ID: ALA5169841

Chembl Id: CHEMBL5169841

PubChem CID: 138577364

Max Phase: Preclinical

Molecular Formula: C24H22ClF3N6O5

Molecular Weight: 566.92

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Cl)cc1-n1nc(C)nc1[C@@H]1O[C@H](CO)[C@H](O)[C@H](n2cc(-c3cc(F)c(F)c(F)c3)nn2)[C@H]1O

Standard InChI:  InChI=1S/C24H22ClF3N6O5/c1-10-29-24(34(31-10)16-7-12(25)3-4-17(16)38-2)23-22(37)20(21(36)18(9-35)39-23)33-8-15(30-32-33)11-5-13(26)19(28)14(27)6-11/h3-8,18,20-23,35-37H,9H2,1-2H3/t18-,20+,21+,22-,23-/m1/s1

Standard InChI Key:  CDOMLWKPZCQCPS-YDXQKAQTSA-N

Alternative Forms

  1. Parent:

    ALA5169841

    ---

Associated Targets(Human)

LGALS3 Tchem Galectin-3 (545 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lgals3 Galectin-3 (98 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 566.92Molecular Weight (Monoisotopic): 566.1292AlogP: 2.31#Rotatable Bonds: 6
Polar Surface Area: 140.57Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.85CX Basic pKa: 0.26CX LogP: 2.47CX LogD: 2.47
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -0.81

References

1. Liu C, Jalagam PR, Feng J, Wang W, Raja T, Sura MR, Manepalli RKVLP, Aliphedi BR, Medavarapu S, Nair SK, Muthalagu V, Natesan R, Gupta A, Beno B, Panda M, Ghosh K, Shukla JK, Sale H, Haldar P, Kalidindi N, Shah D, Patel D, Mathur A, Ellsworth BA, Cheng D, Regueiro-Ren A..  (2022)  Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3.,  65  (16.0): [PMID:35969688] [10.1021/acs.jmedchem.2c00517]

Source